Aviron

• Joany Chou, Plaintiff-Appellant, v. the University of Chicago and Arch Development Corporation, Defendants-Appellees, and Bernard Roizman, Defendant-Appellee, and Aviron Company, Defendant-Appellee., 254 F.3d 1347 (Fed. Cir. 2001)

Appealed from: United States District Court for the Northern District of Illinois, Judge James B. Zagel[Copyrighted Material Omitted][Copyrighted Mate...

• Federal Circuits

• Aviron, Medeva Extend Manufacturing Collaboration.

MOUNTAIN VIEW, Calif. and SPEKE, England--(BW HealthWire)--July 12, 1999-- Aviron (Nasdaq:AVIR) and Medeva Pharma Limited, a subsidiary of Medeva PL...

• Business Wire
• July 12, 1999

• Aviron announces development and licensing agreement with Sang-A.

BURLINGAME, Calif.--(BUSINESS WIRE)--May 15, 1995--Aviron, a privately held biopharmaceutical company developing live vaccine products to prevent vira...

• Business Wire
• May 15, 1995

• Pandemic's Workshop ; Making Policy, Making Money, Making Vaccine

The cost of the nation's strategy to protect its citizens from a global flu pandemic has been substantial. And, its critics claim, hundreds of millions have been misspent in the effort - largely in support of highly profitable multinational drug companies. The benefit, most observers say, has been that despite delays in swine-flu vaccine production, the national policy helped the government respond more quickly to a major public-health threat than ever before.

..., and later by biotechnology company Aviron. MedImmune bought Aviron in 2002, and FluMist went...

• The Washington Times
• December 07, 2009

• Aviron appoints vice president for research and technical affairs.

SAN FRANCISCO--(BUSINESS WIRE)--Jan. 31, 1995--Aviron Tuesday announced it has appointed Martin L. Bryant, M.D., Ph.D., as vice president, research, a...

• Business Wire
• January 31, 1995

• Need for products seen as driver: biotech funding available but 101 Corridor faces challenges in attracting investor interest.

GROWING AN INDUSTRY - Company overview

... interesting deal we did in your area was Aviron, which was later acquired by Medimmune," he says. ...

• San Fernando Valley Business Journal
• April 28, 2008

• Aviron acquires rights to new influenza vaccine in simultaneous agreements with NIH and University of Michigan; vaccine delivered by nasal spray offers advantages for children and adults -- a key element in company's disease prevention focus.

BURLINGAME, Calif.--(BUSINESS WIRE)--March 8, 1995--Aviron Wednesday announced that it signed a Collaborative Research and Development Agreement (CRAD...

• Business Wire
• March 08, 1995

• MaverickTrader.Com Announces Investment Opinion; FREE Ratings on Intel, Exxon, McLeodusa, Extreme Networks, and Aviron.

Business Editors NOTE TO EDITORS: The following is an investment opinion issued by MaverickTrader.Com SHREVEPORT, La.--(BUSINESS WIRE)--Dec. 3, ...

• Business Wire
• December 03, 2001

• Aviron Announces Filing of Registration Statement.

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--July 25, 1997--Aviron (NASDAQ National Market Symbol:AVIR) announced today the filing of a registration statem...

• Business Wire
• July 25, 1997

• Aviron Commences Initial Public Offering of Common Stock.

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Nov. 5, 1996--Aviron Inc. (NASDAQ NMS: AVIR) announced today that it has made an initial public offering of 2 ...

• Business Wire
• November 05, 1996